ACTEMRA

This brand name is authorized in Australia, Brazil, Canada, Ecuador, Hong Kong, Japan, New Zealand, Singapore, Tunisia, Turkey, United States, South Africa

Active ingredients

The drug ACTEMRA contains one active pharmaceutical ingredient (API):

1 Tocilizumab

UNII I031V2H011 - TOCILIZUMAB

Tocilizumab binds specifically to both soluble and membrane-bound IL-6 receptors (sIL-6R and mIL-6R). IL-6 is involved in diverse physiological processes such as T-cell activation, induction of immunoglobulin secretion, induction of hepatic acute phase protein synthesis and stimulation of haemopoiesis. IL-6 has been implicated in the pathogenesis of diseases including inflammatory diseases, osteoporosis and neoplasia.

Read about Tocilizumab

Medication package inserts

Below package inserts are available for further reading:

ACTEMRA Solution for injection

FDA, National Drug Code (US)

MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

L04AC07

Tocilizumab

L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AC Interleukin inhibitors

Discover more medicines within L04AC07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Pharmaceutical Benefits Scheme

Identifier(s): 10056G, 10058J, 10060L, 10064Q, 10068X, 10071C, 10072D, 10073E, 10077J, 10078K, 10079L, 10081N, 10951J, 10954M, 11565Q, 11567T, 11720W, 11721X, 11722Y, 11725D, 11730J, 11734N, 11741Y, 11742B, 11743C, 11744D, 11748H, 11750K, 12083Y, 12084B, 12085C, 12086D, 12090H, 12094M, 12095N, 12099T, 12102Y, 12105D, 1419Q, 1423X, 1464C, 1476Q, 1481Y, 1482B, 9657G, 9658H, 9659J, 9671B, 9672C, 9673D

Câmara de Regulação do Mercado de Medicamentos

Identifier(s): 529208501150212, 529208502157210, 529215110026303, 529220090026707, 529220090026807

Health Products and Food Branch

Identifier(s): 02350092, 02350106, 02350114, 02424770, 02483327

Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

Identifier(s): 202-MBE-0621, 28938-07-09

Department of Health Drug Office

Identifier(s): 59200, 59201, 59202, 63771

医薬品医療機器総合機構

Identifier(s): 6399421A1020, 6399421A2026, 6399421A3022, 6399421G1022, 6399421G2029

Medicines and Medical Devices Safety Authority

Identifier(s): 13435, 15812

Health Sciences Authority

Identifier(s): 13723P, 14837P

Direction de la Pharmacie et du Médicament

Identifier(s): 6993201H, 6993202H, 6993203H, 6993204H

İlaç ve Tıbbi Cihaz Kurumu

Identifier(s): 8699505762272, 8699505762289, 8699505762296, 8699505762302, 8699505762319, 8699505762326, 8699505952840

FDA, National Drug Code

Identifier(s): 50242-135, 50242-136, 50242-137, 50242-138, 50242-143

Health Products Regulatory Authority

Identifier(s): 43/30.1/0944, 43/30.1/0945, 43/30.1/0946, 49/30.1/0398

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.